This represents a monumental advancement for the hemp industry — a comprehensive processing solution from biomass input to T-free crude and/or distillate. This pioneering breakthrough addresses the challenge of processing 'hot' oil with noncompliant THC content, seamlessly processing to a T-free end product. This capability is also indispensable for facilities aspiring to operate under pharmaceutical and Good Manufacturing Practice (GMP) standards.
Read MoreAcquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated environments.
Read MoreENTEXS' CBD Loss Rate of Less Than 5% Means Salus Bioceutical is First Manufacturer Able to Provide Premium Medical-Grade Extracts With Less Than 0.2% THC to Asian Market
Read MoreLuminous Mind Inc. scientists are focused on psychedelic and psychiatric treatments to enhance healthy brain function and to tackle Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. These disorders are among the most serious challenges facing humanity today.
Read MoreLuminous Mind Inc. scientists are focused on psychedelic and psychiatric treatments to enhance healthy brain function and to tackle Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. These disorders are among the most serious challenges facing humanity today.
Read MoreAccuracy options for the CPC6050 Modular Pressure Controller have been enhanced to offer more variety and better accuracy specifications. With these improvements, in addition to 0.01% FS and 0.01% IS-50, users can achieve premium accuracies of 0.008% FS, 0.008% IS-50, and 0.008% IS-33 with the CPR6050.
Read MorePatent-pending technology eliminates need for invasive sensors that clog pipes, reduce flow, slow cleaning, and risk contaminants - high-accuracy HANI sensor mounts outside, measures inside.
Read MoreAcquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use, allowing Pace to support a growing number of clients throughout the drug development process.
Read MoreThe increasing prevalence of respiratory diseases such as chronic bronchitis and chronic obstructive pulmonary disease owing to exposure to industrial emissions, tobacco smoke and indoor pollution should accelerate erdosteine market growth, says this report.
Read MoreRising awareness about health issues among healthcare workers and favorable government regulation to protect healthcare workers from healthcare-acquired infections should accelerate nitrile gloves market growth across the globe., says this report.
Read More